The pharmacokinetics of ceftriaxone were investigated in six healthy adults. One-gram doses were administered either intramuscularly or intravenously in a crossover design study. Mean peak ceftriaxone concentrations in plasma of 79.2 and 123.2 ,ug/ml were achieved with intramuscular injection and intravenous infusion, respectively, with plasma half-lives of 5.4 and 5.8 h. The urinary recovery of ceftriaxone in the first 24 h was 37% after intravenous infusion and 25% after intramuscular injection.
The pharmacokinetic behavior of ceftriaxone was investigated in healthy volunteers to whom 1-g doses were administered intravenously (i.v.) and intramuscularly (i.m.) in a crossover study.
Six healthy adults, four males and two females (average age, 40.3 ± 14.6 years; average body surface area, 1.9 ± 0.2 m2), were studied. All subjects gave written informed consent. The prestudy physical exam, hemogram, prothrombin time, and urinalysis were normal for each subject. Ceftriaxone was reconstituted in normal saline and 5% glucose for i.v. solutions and in 1% lidocaine for i.m. injection. Each subject received 1-g doses of ceftriaxone i.v., given as a 30-min infusion of 50 ml, and 10 ml i.m. at 1-week intervals, following a random crossover design. Subjects fasted overnight before drug administration and for 2 h thereafter and were sedentary during the study. Blood specimens were drawn from heparin locks inserted into the arm (contralateral during i.v. infusion) at 15, 30 (end of infusion), 40, 50, 60, and 90 min, at hourly intervals for another 10 h, and at 24 h after i.v. or i.m. doses. The blood was collected into preheparinized tubes, and plasma, separated by centrifugation, was stored at -65°C until analyzed.
Urine was collected before dosage and at 0 to 2, 2 to 4, 4 to 8, and 8 to 24 h. Volumes were recorded, and samples were filtered and stored at -65°C until assayed. Each plasma sample was deproteinized by adding 2.0 ml of acetonitrile and 0.75 ml of water to 0.25 ml of the sample in a test tube, followed by stirring for 15 The total quantity of ceftriaxone excreted between 4 and 8 h was 98 mg; 25% of the administered dose was excreted in the urine in the first 24-h period ( Table 2) . The concentrations in plasma and urine after i.v. infusion observed in our study generally agree with those reported by Patel et al. (11) . Volunteers given 1 g i.v. in our study excreted 37% of the administered dose in the urine in 24 h, whereas 44% was reported by Patel et al. (12) and 50% by Seddon et al. after 0.5-g doses (14) . Similarly, after i.m. injection of 1 g in our study, 25% of the dose was excreted in 24 h, whereas Patel et al. (13) found that 34% was excreted after 0.5-g doses. There are extrarenal mechanisms for the elimination of ceftriaxone. Arvidsson et al. (2) 
